This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov;15(4):96.

doi: 10.1136/eb-2012-100967. Epub 2012 Sep 23.

Atomoxetine reduces ADHD symptoms in children with autism spectrum disorder

L Eugene Arnold¹; Children with Hyperactivity & ASD Research Treatment Study (CHARTS) Consortium

Affiliations

PMID: 23002102
DOI: 10.1136/eb-2012-100967

Comment

Atomoxetine reduces ADHD symptoms in children with autism spectrum disorder

L Eugene Arnold et al. Evid Based Ment Health. 2012 Nov.

. 2012 Nov;15(4):96.

doi: 10.1136/eb-2012-100967. Epub 2012 Sep 23.

Authors

L Eugene Arnold¹; Children with Hyperactivity & ASD Research Treatment Study (CHARTS) Consortium

Affiliation

¹ The Nisonger Center, Ohio State University, Columbus, OH, USA.

PMID: 23002102
DOI: 10.1136/eb-2012-100967

No abstract available

PubMed Disclaimer

Comment on

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, Pamulapati S, Buitelaar JK, Hoekstra PJ. Harfterkamp M, et al. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. doi: 10.1016/j.jaac.2012.04.011. Epub 2012 May 25. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 22721596 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.